Ikarian Capital, LLC Stealth Bio Therapeutics Corp Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.32 $13,264 - $21,222	-66,320 Reduced 13.22%	435,516 $134,000
Q1 2022 May 13, 2022	BUY	$0.49 - $0.9 $11,404 - $20,947	23,275 Added 4.86%	501,836 $350,000
Q3 2021 Nov 15, 2021	SELL	$1.17 - $1.58 $11,060 - $14,935	-9,453 Reduced 1.94%	478,561 $651,000
Q2 2021 Aug 16, 2021	SELL	$1.07 - $1.77 $321,000 - $531,000	-300,000 Reduced 38.07%	488,014 $761,000
Q1 2021 May 17, 2021	BUY	$1.38 - $2.42 $1.04 Million - $1.82 Million	750,417 Added 1995.95%	788,014 $1.24 Million
Q4 2019 Jan 31, 2020	BUY	$3.26 - $13.7 $122,566 - $515,078	37,597 New	37,597 $123,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.